Filing Details
- Accession Number:
- 0000950170-25-078971
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-29 16:15:05
- Reporting Period:
- 2025-05-27
- Filing Date:
- 2025-05-29
- Accepted Time:
- 2025-05-29 16:15:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1802255 | Guardian Pharmacy Services Inc. | GRDN | Retail-Drug Stores And Proprietary Stores (5912) | 200100834 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2037898 | John Ackerman | 300 Galleria Parkway Se, Suite 800 Atlanta GA 30339 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2025-05-27 | 813,318 | $20.16 | 600,622 | No | 4 | S | Indirect | By Pharmacy Investors, LLC |
Class A Common Stock | Disposition | 2025-05-27 | 270,958 | $20.16 | 200,099 | No | 4 | S | Indirect | By Cardinal Equity Fund, L.P. |
Class A Common Stock | Disposition | 2025-05-28 | 150,998 | $20.16 | 449,624 | No | 4 | S | Indirect | By Pharmacy Investors, LLC |
Class A Common Stock | Disposition | 2025-05-28 | 50,305 | $20.16 | 149,794 | No | 4 | S | Indirect | By Cardinal Equity Fund, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Pharmacy Investors, LLC |
No | 4 | S | Indirect | By Cardinal Equity Fund, L.P. |
No | 4 | S | Indirect | By Pharmacy Investors, LLC |
No | 4 | S | Indirect | By Cardinal Equity Fund, L.P. |
Footnotes
- Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein.